Healthcare provider profile · identity verified

Jeffrey B Allan, MD

Internal Medicine · CAMARILLO, CA · NPI 1407870652

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	514	130
Levothyroxine Sodium	Levothyroxine Sodium	455	115
Amlodipine Besylate	Amlodipine Besylate	286	72
Donepezil Hcl	Donepezil Hcl	286	56
Tamsulosin Hcl	Tamsulosin Hcl	278	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	245	53
Pantoprazole Sodium	Pantoprazole Sodium	211	57
Losartan Potassium	Losartan Potassium	206	54
Alprazolam	Alprazolam	193	59
Lisinopril	Lisinopril	187	53
Metoprolol Succinate	Metoprolol Succinate	187	54
Omeprazole	Omeprazole	173	51
Tramadol Hcl	Tramadol Hcl	172	40
Simvastatin	Simvastatin	163	48
Gabapentin	Gabapentin	155	52
Warfarin Sodium	Warfarin Sodium	154	11
Zolpidem Tartrate	Zolpidem Tartrate	151	37
Trazodone Hcl	Trazodone Hcl	144	44
Metformin Hcl	Metformin Hcl	137	42
Quetiapine Fumarate	Quetiapine Fumarate	135	24
Eliquis	Apixaban	129	34
Alendronate Sodium	Alendronate Sodium	126	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	126	23
Escitalopram Oxalate	Escitalopram Oxalate	121	32
Meloxicam	Meloxicam	121	39
Furosemide	Furosemide	120	39
Xarelto	Rivaroxaban	116	24
Finasteride	Finasteride	111	28
Hydrochlorothiazide	Hydrochlorothiazide	98	30
Rosuvastatin Calcium	Rosuvastatin Calcium	98	32
Sertraline Hcl	Sertraline Hcl	98	20
Mirtazapine	Mirtazapine	96	23
Triamcinolone Acetonide	Triamcinolone Acetonide	89	35
Citalopram Hbr	Citalopram Hydrobromide	88	24
Duloxetine Hcl	Duloxetine Hcl	87	24
Allopurinol	Allopurinol	85	23
Lorazepam	Lorazepam	84	22
Levetiracetam	Levetiracetam	83	13
Famotidine	Famotidine	82	18
Memantine Hcl	Memantine Hcl	80	16
Oxycodone Hcl	Oxycodone Hcl	77	suppressed
Clopidogrel	Clopidogrel Bisulfate	75	21
Myrbetriq	Mirabegron	75	15
Ezetimibe	Ezetimibe	73	21
Potassium Chloride	Potassium Chloride	71	20
Metoprolol Tartrate	Metoprolol Tartrate	70	17
Albuterol Sulfate Hfa	Albuterol Sulfate	67	23
Pravastatin Sodium	Pravastatin Sodium	66	21
Pregabalin	Pregabalin	65	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	64	14
Synthroid	Levothyroxine Sodium	64	22
Pioglitazone Hcl	Pioglitazone Hcl	60	14
Atenolol	Atenolol	57	14
Amiodarone Hcl	Amiodarone Hcl	55	15
Temazepam	Temazepam	55	13
Fluoxetine Hcl	Fluoxetine Hcl	53	15
Spironolactone	Spironolactone	53	15
Hydromorphone Hcl	Hydromorphone Hcl	52	suppressed
Clonazepam	Clonazepam	51	suppressed
Jardiance	Empagliflozin	50	suppressed
Diclofenac Sodium	Diclofenac Sodium	49	17
Carvedilol	Carvedilol	47	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	11
Oxycontin	Oxycodone Hcl	47	suppressed
Valsartan	Valsartan	47	12
Digoxin	Digoxin	46	suppressed
Ondansetron Odt	Ondansetron	45	suppressed
Entresto	Sacubitril/Valsartan	44	suppressed
Midodrine Hcl	Midodrine Hcl	43	suppressed
Liothyronine Sodium	Liothyronine Sodium	42	13
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Ondansetron Hcl	Ondansetron Hcl	41	22
Paxlovid	Nirmatrelvir/Ritonavir	41	41
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Celecoxib	Celecoxib	39	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	27
Lidocaine	Lidocaine	39	15
Buspirone Hcl	Buspirone Hcl	37	12
Prednisone	Prednisone	36	suppressed
Bumetanide	Bumetanide	35	suppressed
Montelukast Sodium	Montelukast Sodium	34	12
Diclofenac Potassium	Diclofenac Potassium	33	suppressed
Estradiol	Estradiol	33	14
Terazosin Hcl	Terazosin Hcl	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	13
Metformin Hcl Er	Metformin Hcl	30	suppressed
Fentanyl	Fentanyl	29	suppressed
Methylprednisolone	Methylprednisolone	29	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Rivastigmine	Rivastigmine	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Ozempic	Semaglutide	27	suppressed
Cephalexin	Cephalexin	26	22
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	18
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Carisoprodol	Carisoprodol	22	suppressed
Diazepam	Diazepam	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Mupirocin	Mupirocin	21	suppressed
Nystatin	Nystatin	21	12
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Latanoprost	Latanoprost	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Brilinta	Ticagrelor	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Valproic Acid	Valproic Acid	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Topiramate	Topiramate	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Azithromycin	Azithromycin	14	13
Clozapine	Clozapine	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Ramipril	Ramipril	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Travoprost	Travoprost	13	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	12	suppressed
Colchicine	Colchicine	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clonidine	Clonidine	11	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error